Stereotactic Body Radiation Therapy trials for Lung Non-Small Cell Carcinoma

All Stereotactic Body Radiation Therapy trials · All Lung Non-Small Cell Carcinoma trials

Phase breakdown

Recruiting trials studying Stereotactic Body Radiation Therapy for Lung Non-Small Cell Carcinoma

• Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma
  NCT06014827 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma
  NCT05830058 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study
  NCT05802186 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Stereotactic Body Radiation Therapy for Lung Non-Small Cell Carcinoma?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.